MetaCap

Alamar Biosciences Financial Statements

NASDAQ: ALMRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

25.27-0.64 (-2.47%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Alamar Biosciences has no annual income statement on file yet, so quarterly figures are shown instead.

Alamar Biosciences revenue and earnings

In the quarter ended Jun 30, 2026, Alamar Biosciences generated $29.4 million in revenue. Alamar Biosciences reported a net loss of $13.2 million. Gross margin was 60.2% and operating margin -46.0%.

Diluted earnings per share came in at -$0.22.

Summary generated from market data by MetaCap's automated system. Methodology

Alamar Biosciences income statement (quarterly)

Alamar Biosciences quarterly income statement
Quarter (USD)Q2 20262026-06-30Q1 20262026-03-31Q? 20252025-06-30Q? 20252025-03-31
Revenue29.43M26.04M16.16M13.09M
Revenue growth (YoY)————
Cost of Revenue11.71M11.58M7.58M6.70M
Gross Profit17.72M14.46M8.58M6.39M
Operating Expenses31.25M26.80M16.50M14.94M
Research & Development13.82M13.02M8.89M8.30M
Selling, General & Admin17.43M13.79M7.61M6.64M
Operating Income-13.53M-12.35M-7.92M-8.55M
Interest Expense224.00K223.00K48.00K46.00K
Pretax Income-13.29M-20.86M-7.02M-7.66M
Income Tax-93.00K464.00K——
Net Income-13.20M-21.32M-7.02M-7.66M
Net Income growth (YoY)————
EPS (Basic)-0.22-1.74-0.62-0.68
EPS (Diluted)-0.22-1.74-0.62-0.68
Shares Outstanding (Basic)58.67M12.26M11.41M11.26M
Shares Outstanding (Diluted)58.67M12.26M11.41M11.26M
EBITDA-12.40M-11.18M-7.00M-7.67M
Gross Margin60.21%55.53%53.09%48.80%
Operating Margin-45.98%-47.42%-49.00%-65.33%
Net Margin-44.85%-81.91%-43.45%-58.51%

This table shows 4 quarterly periods of Alamar Biosciences's income statement, from Q2 2026 back to Q? 2025, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ALMR's reporting calendar. What is a income statement?

More financial data